Scilex Holding Co. Announces CEO Resignation Amid Strategic Merger and Funding for Non-Opioid Pain Drug
Scilex Holding Company is undergoing leadership changes, including the resignation of CEO Jaisim Shah, as the company shifts its focus towards the merger of its subsidiary Semnur Pharmaceuticals with Denali Capital Acquisition Corp.
2 minutes to read